Publication
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation
Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48)
Mark S. Link, Mark S. Link, Robert P. Giugliano, Robert P. Giugliano, Christian T. Ruff, Christian T. Ruff, Benjamin M. Scirica, Benjamin M. Scirica, Heikke Huikuri, Heikke Huikuri, Ali Oto, Ali Oto, Andrea E. Crompton, Andrea E. Crompton, Sabina A. Murphy, Sabina A. Murphy, Hans Lanz, Hans Lanz, Michele F. Mercuri, Michele F. Mercuri, Elliott M. Antman, Elliott M. Antman, Eugene Braunwald, Eugene Braunwald
Circulation Arrhythmia and Electrophysiology, January 2017, Wolters Kluwer Health
DOI: 10.1161/circep.116.004267